FAKTOR-OPTIONSSCHEIN - UCB Stock

DE000SR8WD51

Market Closed - Deutsche Boerse AG 15:44:43 2024-05-09 EDT
0.11 ^EUR	+10.00%

Current month	+25.00%
1 month	-21.43%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB presents final open-label extension F data at International Child Neurology Congress Annual Meeting	05-09	AQ
UCB : presents final open-label extension F®▼(fenfluramine) data at International Child Neurology Congress (ICNC) Annual Meeting	05-08	PU
UCB - Acquisition of own shares	05-06	AQ
UCB : Acquisition of own shares	04-26	PU

More news

Quotes 5-day view

Date	Price	Change
24-05-09	0.11	+10.00%
24-05-08	0.1	0.00%
24-05-07	0.1	0.00%
24-05-06	0.1	0.00%
24-05-03	0.1	0.00%

Delayed Quote Deutsche Boerse AG

Last update May 09, 2024 at 03:44 pm

More quotes

Static data

Product type	Produits Exotiques
Buy / Sell	CALL
Underlying	UCB
Issuer	Société Générale
WKN	SR8WD5
ISIN	DE000SR8WD51
Date issued	2020-05-28
Strike	82.97 €
Maturity	Unlimited
Parity	1 : 1
Emission price	10.15 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	10.43 €
Lowest since issue	0.085 €
Spread	0.01 €
Spread %	8.33%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

118.8 EUR

Average target price

125.5 EUR

Spread / Average Target

+5.68%

Consensus